1. Home
  2. CGON vs SBCF Comparison

CGON vs SBCF Comparison

Compare CGON & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • SBCF
  • Stock Information
  • Founded
  • CGON 2010
  • SBCF 1926
  • Country
  • CGON United States
  • SBCF United States
  • Employees
  • CGON 61
  • SBCF N/A
  • Industry
  • CGON
  • SBCF Major Banks
  • Sector
  • CGON
  • SBCF Finance
  • Exchange
  • CGON NYSE
  • SBCF Nasdaq
  • Market Cap
  • CGON 2.2B
  • SBCF 2.5B
  • IPO Year
  • CGON 2024
  • SBCF N/A
  • Fundamental
  • Price
  • CGON $32.84
  • SBCF $29.50
  • Analyst Decision
  • CGON Strong Buy
  • SBCF Hold
  • Analyst Count
  • CGON 8
  • SBCF 5
  • Target Price
  • CGON $63.88
  • SBCF $28.10
  • AVG Volume (30 Days)
  • CGON 396.6K
  • SBCF 433.8K
  • Earning Date
  • CGON 11-12-2024
  • SBCF 10-24-2024
  • Dividend Yield
  • CGON N/A
  • SBCF 2.44%
  • EPS Growth
  • CGON N/A
  • SBCF 10.93
  • EPS
  • CGON N/A
  • SBCF 1.36
  • Revenue
  • CGON $684,000.00
  • SBCF $494,135,000.00
  • Revenue This Year
  • CGON $411.76
  • SBCF N/A
  • Revenue Next Year
  • CGON $405.27
  • SBCF $8.42
  • P/E Ratio
  • CGON N/A
  • SBCF $21.70
  • Revenue Growth
  • CGON 258.12
  • SBCF N/A
  • 52 Week Low
  • CGON $25.77
  • SBCF $21.23
  • 52 Week High
  • CGON $50.23
  • SBCF $30.78
  • Technical
  • Relative Strength Index (RSI)
  • CGON 41.08
  • SBCF 60.06
  • Support Level
  • CGON $35.12
  • SBCF $29.09
  • Resistance Level
  • CGON $40.47
  • SBCF $30.71
  • Average True Range (ATR)
  • CGON 1.69
  • SBCF 0.85
  • MACD
  • CGON -0.28
  • SBCF 0.18
  • Stochastic Oscillator
  • CGON 4.57
  • SBCF 72.05

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.

Share on Social Networks: